Food Allergy Clinical Trials 2024

Food Allergy Clinical Trials 2024

Food Allergy research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in food allergy clinical trials today.

Food Allergy Clinical Trials

Here are the 6 most popular medical studies for food allergy

Popular filter options for food allergy trials

Peanut Allergy Clinical Trials

View 8 Peanut Allergy medical studies.

Food Allergy Clinical Trials With No Placebo

View 22 food allergy medical studies that do not have a placebo group.

View More Food Allergy Trials

See another 3 medical studies focused on food allergy.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to food allergy

What are the top hospitals conducting food allergy research?

When it comes to advancing our understanding and treatment of food allergies, several leading hospitals are at the forefront of clinical trials. In New york City, the Icahn School of Medicine at Mount Sinai is making significant strides with three ongoing food allergy trials. While they have only recorded one trial in this field thus far, their commitment to research and innovation is evident. Boston's Massachusetts General Hospital also plays a crucial role in this arena, currently conducting two active food allergy trials. Although they do not have any previous recorded trials specifically focused on food allergies, their expertise and resources make them an important contributor to the field.

Heading down south to Washington D.C., Childrens' National Hospital is dedicated to improving our understanding of food allergies through one ongoing clinical trial. Similarly, Novartis Investigative Site in Ypsilanti and San Jose are each engaged in advancing knowledge about food allergies with one active trial each.

These institutions across different locations signify the collective effort being made towards unraveling the complexities surrounding food allergies—a condition that affects millions worldwide. By conducting these essential clinical trials, researchers aim to find novel treatments and therapies that can alleviate symptoms or even prevent allergic reactions altogether. The dedication shown by these hospitals underscores not just their commitment but also their profound compassion for those living with this challenging medical condition—and gives hope for a future where individuals can enjoy meals without fear or restriction

Which are the best cities for food allergy clinical trials?

New york, New York; Boston, Massachusetts; and Baltimore, Maryland emerge as the most promising cities for food allergy clinical trials. These locations offer a range of ongoing studies focused on various treatments such as Ligelizumab 120 mg, Abrocitinib 100mg, peanut oral immunotherapy, and more. With five active trials in New York City, four in Boston, and three in Baltimore—all investigating innovative approaches to managing food allergies—these cities provide individuals with opportunities to participate in cutting-edge research that may pave the way for improved treatment options and enhanced quality of life.

Which are the top treatments for food allergy being explored in clinical trials?

When it comes to the exploration of treatments for food allergy in clinical trials, there are a few standout contenders. One such treatment being investigated is oral immunotherapy, which involves gradually introducing small amounts of the allergen into the patient's diet to build tolerance. Another promising avenue is sublingual immunotherapy, where drops or tablets containing extracts of the allergen are placed under the tongue. These approaches aim to desensitize individuals and reduce allergic reactions over time. Exciting advancements are also being made with biologics, specifically anti-IgE antibodies that target and neutralize allergic responses. With ongoing research and development in these areas, hope continues to grow for effective solutions to combat food allergies.

What are the most recent clinical trials for food allergy?

Significant progress is being made in the field of food allergy research, with recent clinical trials offering promising insights into potential treatments. One such trial investigated the use of antibiotics combined with microbiota-targeted therapy (MTT) in managing food allergies. The results from this Phase 2 study demonstrated encouraging outcomes for patients. Additionally, a Phase 3 trial evaluated ligelizumab at a dosage of 120 mg as a treatment option for food allergy sufferers. Another noteworthy trial explored abrocitinib at a strength of 100mg and its efficacy in addressing food allergies during its Phase 1 stage. Finally, two trials—ADP101 and prebiotic—have shown positive developments during their respective Phase 1 and Phase 2 stages. These exciting clinical trials offer hope to those living with food allergies, indicating advancements in understanding and potentially mitigating allergic responses to certain foods.

What food allergy clinical trials were recently completed?

A recently completed clinical trial focused on food allergies highlights the ongoing efforts to advance treatments in this field. In December 2021, Johns Hopkins University successfully wrapped up a trial investigating Acalabrutinib's potential impact on food allergy management. This study constitutes an important step forward in our understanding of how to address and potentially alleviate the challenges faced by individuals with food allergies. The findings of this trial contribute valuable insights that may pave the way for improved therapies and enhanced quality of life for those affected by these conditions.